Bone Therapeutics Granted Additional EUR 2MM in Funding

Bone Therapeutics was granted an additional €2MM (~US $2.15MM) in non-dilutive funding from the Belgian Walloon Region government, bringing the total non-dilutive funding received within 2015 to €5MM.

The new funding will support a 2-year study of ALLOB® allogeneic bone cell therapy, investigating the impact of proteins on...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us